Author/Creator: Serruys, B. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Serruys, B.

1. Pharmacokinetic and pharmacodynamic modelling of the novel anti-ADAMTS-5 nanobody M6495 using the neo-epitope ARGS as a biomarker. (April 2018)

Authors:: Pereira, J.; Ottevaere, I.; Serruys, B.; Dejonckheere, E.; Bay-Jensen, A.-C.; Siebuhr, A.-S.; El Bawab, S.; Ladel, C.; Lindemann, S.
Journal:: Osteoarthritis and cartilage
Issue:: Volume 26(2018)Supplement 1
Page Start:: S176
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Structural and symptomatic benefit of a half-live extended, systemically applied anti-ADAMTS-5 inhibitor (M6495). (April 2018)

Authors:: Brenneis, C.; Serruys, B.; Van Belle, T.; Poelmans, S.; Kleinschmidt-Doerr, K.; Guehring, H.; Michaelis, M.; Lindemann, S.
Journal:: Osteoarthritis and cartilage
Issue:: Volume 26(2018)Supplement 1
Page Start:: S299
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. The anti-ADAMTS-5 nanobody®, M6495, protects against cartilage breakdown in cartilage and synovial joint tissue explant models. (April 2018)

Authors:: Siebuhr, A.; Bay-Jensen, A.-C.; Thudium, C.T.; Karsdal, M.A.; Serruys, B.; Werkmann, D.; Michaelis, M.; Ladel, C.; Lindemann, S.
Journal:: Osteoarthritis and cartilage
Issue:: Volume 26(2018)Supplement 1
Page Start:: S187
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗